Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $IBPI Ardea Biosciences, Inc./DE
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in Ardea Biosciences, Inc./DE
Trading Symbol: IBPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Baker Brothers Life Sciences Capital (GP), LLC: Director, 10% Owner
Holdings: 4,036,097 shares
Latest Transaction: Jan 24 2011
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in Ardea Biosciences, Inc./DE
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 24 2011 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 26.00 | 355,585 | 9,245,210 | 4,036,097 | 3.7 M to 4 M (+9.66 %) |
Apr 08 2010 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | Director | Buy | P | 20.00 | 486,569 | 9,731,380 | 3,680,512 | 3.2 M to 3.7 M (+15.23 %) |
Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | P | 11.14 | 147,292 | 1,640,833 | 147,292 | |
Dec 19 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 11.14 | 589,169 | 6,563,343 | 3,193,943 | 2.6 M to 3.2 M (+22.62 %) |
May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | C | 0.00 | 63 | 0 | 0 | |
May 16 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | C | 0.00 | 331,452 | 0 | 2,604,774 | 2.3 M to 2.6 M (+14.58 %) |
Apr 21 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.28 | 27,982 | 371,601 | 2,273,322 | 2.2 M to 2.3 M (+1.25 %) |
Apr 08 2008 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.28 | 313,169 | 4,158,884 | 2,245,340 | 1.9 M to 2.2 M (+16.21 %) |
Dec 21 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | X | 1.03 | 165,727 | 171,196 | 0 | |
Dec 21 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 13.25 | 754,519 | 9,997,377 | 1,930,363 | 1.2 M to 1.9 M (+64.17 %) |
Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | X | 1.03 | 165,727 | 171,196 | 0 | |
Jun 13 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | X | 1.03 | 165,727 | 171,196 | 1,172,221 | 1 M to 1.2 M (+16.47 %) |
Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 6.00 | 35,469 | 212,814 | 1,000,982 | 965.5 K to 1 M (+3.67 %) |
Jan 26 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.98 | 11,847 | 70,897 | 965,513 | 953.7 K to 965.5 K (+1.24 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 5.28 | 56,822 | 299,833 | 953,666 | 896.8 K to 953.7 K (+6.34 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 4.83 | 17,735 | 85,660 | 896,844 | 879.1 K to 896.8 K (+2.02 %) |
Jan 11 2007 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 4.77 | 24,899 | 118,733 | 879,109 | 854.2 K to 879.1 K (+2.91 %) |
Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 4.00 | 82,998 | 331,992 | 854,210 | 771.2 K to 854.2 K (+10.76 %) |
Dec 27 2006 | IBPI | Ardea Biosciences, ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 3.85 | 154,646 | 595,557 | 771,212 | 616.6 K to 771.2 K (+25.08 %) |
Page: 1